Information about REPL Dr. Advice No.164 Amenorin Drop
REPL Dr. Advice No.164 Amenorin Drop
REPL Dr. Advice No.164 Amenorin Drop Amenorrhea is not a disease and it does not mean that a person is infertile but it can be a sign of a health problem that needs some attention. Around puberty, during pregnancy menstruation also stops and it is common for it to stop. If menstruation does not occur at times when people normally expect it to, this is a headache. Vision changes, and additional facial hair, are the main symptoms is a lack of menstruation. Repl dr. Advice no. 164 amenorin is prescribed for the symptoms associated with amenorrhea such as excess facial hair, pelvic pain, and acne. Helpful in the condition of cramping in the lower abdomen, pain in the lower abdomen and/or lower back, and pain radiating down the legs.
REPL Dr. Advice No.164 Amenorin Drop Amenorrhea is not a disease and it does not mean that a person is infertile but it can be a sign of a health problem that needs some attention. Around puberty, during pregnancy menstruation also stops and it is common for it to stop. If menstruation does not occur at times when people normally expect it to, this is a headache. Vision changes, and additional facial hair, are the main symptoms is a lack of menstruation. Repl dr. Advice no. 164 amenorin is prescribed for the symptoms associated with amenorrhea such as excess facial hair, pelvic pain, and acne. Helpful in the condition of cramping in the lower abdomen, pain in the lower abdomen and/or lower back, and pain radiating down the legs.
Key Ingredients:
Aconitum Napellus 6,Pulsatilla Q,Secale cornutum Q,Bryonia Alba 1X,Sepia Officinalis 6,Natrum Muriaticum 6
Key Benefits:
- may help support symptoms associated with menstrual irregularities
Directions For Use:
- 10 drops with 1/4th cup water 3 times daily for 6 months to 1 year or as prescribed by a physician.
Safety Information:
- Shake well before use
- Keep away from the reach of children
- Store in a cool and dark place




Reviews
There are no reviews yet.